REGENXBIO INC. – Trademark Portfolio
Entity Type: 03
REGENXBIO INC. holds 45 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 27 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 22 trademarks are registered and 11 are pending. Notable registered marks include NAV, ASCENT, AAVIATE, AFFINITY, and ALTITUDE. The owner is based in Rockville, MD.
9804 Medical Center Drive
Rockville, MD 20850
Showing of trademarks Trademarks
Trademark Classifications
REGENXBIO INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does REGENXBIO INC. have?
REGENXBIO INC. has 45 U.S. trademarks filed with the USPTO. Of these, 22 registered, 11 pending, 11 abandoned, 1 cancelled.
What trademark classes does REGENXBIO INC. file in?
REGENXBIO INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 40 (Treatment & Processing). Class 42 covers scientific and technological services; industrial analysis and research services.
What are REGENXBIO INC.'s most well-known trademarks?
REGENXBIO INC.'s registered trademark portfolio includes well-known marks such as NAV, ASCENT, AAVIATE, AFFINITY, and ALTITUDE. These are among 22 currently registered trademarks in the portfolio.
What is REGENXBIO INC.'s trademark registration success rate?
REGENXBIO INC. has a 65% trademark registration rate, with 22 out of 34 resolved applications resulting in successful registration. Currently, 11 applications are pending review.